Skip to main content
. 2021 Oct 20;12:754503. doi: 10.3389/fgene.2021.754503

FIGURE 3.

FIGURE 3

The lncRNA signature for predicting recurrence PFS of patients with NFPA. Kaplan–Meier survival curves of patients classified into high- and low-risk groups using the lncRNA signature in the training (A), test (B) and entire dataset (C).